
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Legius syndrome
Introduction
Synonyms and keywords: Neurofibromatosis, type 1-like syndrome
Overview
Overview
Legius syndrome (LS) is an autosomal dominant condition characterized by cafe au lait spots.[1]
Historical Perspective
Historical Perspective
- It was first described in 2007 and is often mistaken for Neurofibromatosis type I (NF-1).
- The syndrome is named after Eric Legius, Professor at the Katholieke Universiteit Leuven|Catholic University of Leuven.
Differentiating Legius syndrome from other Diseases
Differentiating Legius syndrome from other Diseases
- Features common in neurofibromatosis – lisch nodules, bone abnormalities, neurofibromas, optic nerve gliomas and malignant peripheral nerve sheath tumors – are absent in this condition.
- The similarity of symptoms stem from the fact that the different genes affected in the two syndromes code for proteins that carry out a similar task in the same reaction pathway.
- A genetic test is often the only way to make sure a person has Legius syndrome and not NF-1.
- Because of this difference, Legius syndrome is often seen as the less severe of the two syndromes.
Diagnosis
Diagnosis
Symptoms
Physical Examination
Skin
- Nearly all patients show multiple café au lait spots.
- Freckles in the armpits and/or groin
- Lipomas
Head
Neurologic
Other
Other Diagnostic Studies
- Genetic testing is necessary to identify the syndrome.
- The test checks for loss of function mutations in the SPRED1 gene.
References
References
- ↑ “Legius syndrome”, Genetics Home Reference, National Institutes of Health
- ↑ “SPRED1”, Genetics Home Reference, National Institutes of Health
- ↑ “Legius Syndrome Often Mistaken for Neurofibromatosis Type 1”, by Allison Gandley, November 18, 2009, Medscape
- ↑ “Legius Syndrome (SPRED1) Sequencing & (NF1) Sequencing Exon 22 (Exon 17)”, May 2010, ARUP Laboratories
- ↑ 5.0 5.1 [1], Pagon RA, Bird TD, Dolan CR, et al.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[3]
